Join the 'Polio' group to help and get support from people like you.
Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age
Posted 25 Mar 2015 by Drugs.com
SWIFTWATER, Pa., March 25, 2015 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi , announced today that the U.S. Food and Drug Administration (FDA) has approved use of Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus; DTaP-IPV) vaccine for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children 4 through 6 years of age. "The FDA approval of Quadracel vaccine provides health care providers with a new combination vaccine, potentially reducing the number of vaccine injections children aged 4 through 6 would need," said David P. Greenberg, M.D., Vice President, U.S. Scientific and Medical Affairs, Sanofi Pasteur. "Our goal is to help remove barriers to timely immunization and we think this combination vaccine could help ensure children are getting vaccinated in line with current ... Read more
Related support groups: Tetanus, Vaccination, Tetanus Toxoid, Polio, Pertussis, Diphtheria, Poliovirus Vaccine, Inactivated, Pertussis, Acellular, Poliomyelitis Prophylaxis, Vaccination and Prophlaxis, Tetanus Prophylaxis, Tetanus Toxoid Adsorbed, Pertussis Prophylaxis, Diphtheria Prophylaxis